Veritti, Daniele http://orcid.org/0000-0003-0148-5348
Sarao, Valentina http://orcid.org/0000-0003-0041-5073
Chhablani, Jay http://orcid.org/0000-0003-1772-3558
Loewenstein, Anat http://orcid.org/0000-0002-7706-1165
Lanzetta, Paolo http://orcid.org/0000-0003-3746-141X
Bandello, Francesco
Midena, Edoardo
Nicolò, Massimo
Parravano, Mariacristina
Pilotto, Elisabetta
Ricci, Federico
Staurenghi, Giovanni
Virgili, Gianni
Arnold, Jennifer J.
Augustin, Albert J.
Creuzot-Garcher, Catherine
Adrian, Monica Lövestam
Mekjavić, Polona Jaki
Patel, Praveen J.
Rodriguez, Francisco J.
Schumann, Ricarda
Sharma, Ashish
Silva, Rufino
Zarranz-Ventura, Javier
,
,
Funding for this research was provided by:
Università degli Studi di Udine
Article History
Received: 31 January 2023
Revised: 2 May 2023
Accepted: 8 May 2023
First Online: 18 May 2023
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Daniele Veritti, Valentina Sarao and Jay Chhablani declare they have no financial interests. Anat Loewenstein is a consultant to Iveric Bio, Beyeonics, Bayer, WebMD, Allergan, Roche, Novartis, Notal Vision; Paolo Lanzetta is a consultant to Abbvie, Aerie, Apellis, Bausch & Lomb, Bayer, Biogen, Boehringer Ingelheim, Genentech, I-Care, Novartis, Ocular Therapeutix, Outlook Therapeutics, and Roche.